MedTrace Logo

Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer

NCT01561170 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2015-04-10

No results posted yet for this study

Summary

Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer.

The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.

Conditions

  • Chronic Venous Hypertension With Ulcer and Inflammation
  • Venous Ulcer Pain

Interventions

DEVICE

Active Pulsed Electro-Magnetic Field (PEMF)

One group of patients receive active devices. Both patients and investigator are blinded.

DEVICE

Placebo Pulsed Electro-Magnetic Field (PEMF)

One group of patients receive placebo devices. Both patients and investigator are blinded.

Sponsors & Collaborators

  • Northern Orthopaedic Division, Denmark

    lead OTHER

Principal Investigators

  • Vesal Khalid, M.D. · Northern Orthopaedic Department, Aalborg University Hospital, Denmark

  • Nils Johannesen, M.D. · Cardiology Department, Aalborg University Hospital, Denmark

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01561170 on ClinicalTrials.gov